347 related articles for article (PubMed ID: 36142403)
1. MicroRNAs, Stem Cells in Bipolar Disorder, and Lithium Therapeutic Approach.
Coradduzza D; Garroni G; Congiargiu A; Balzano F; Cruciani S; Sedda S; Nivoli A; Maioli M
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142403
[TBL] [Abstract][Full Text] [Related]
2. Cortical thickness and subcortical volumes alterations in euthymic bipolar I patients treated with different mood stabilizers.
Li L; Ji E; Han X; Tang F; Bai Y; Peng D; Fang Y; Zhang S; Zhang Z; Yang H
Brain Imaging Behav; 2019 Oct; 13(5):1255-1264. PubMed ID: 30145720
[TBL] [Abstract][Full Text] [Related]
3. Abelson Helper Integration Site 1 haplotypes and peripheral blood expression associates with lithium response and immunomodulation in bipolar patients.
Sakrajda K; Bilska K; Czerski PM; Narożna B; Dmitrzak-Węglarz M; Heilmann-Heimbach S; Brockschmidt FF; Herms S; Nöthen MM; Cichon S; Więckowska B; Rybakowski JK; Pawlak J; Szczepankiewicz A
Psychopharmacology (Berl); 2024 Apr; 241(4):727-738. PubMed ID: 38036661
[TBL] [Abstract][Full Text] [Related]
4. RNA Biomarkers in Bipolar Disorder and Response to Mood Stabilizers.
Pisanu C; Squassina A
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373213
[TBL] [Abstract][Full Text] [Related]
5. Transcriptomics and miRNomics data integration in lymphoblastoid cells highlights the key role of immune-related functions in lithium treatment response in Bipolar disorder.
Cattane N; Courtin C; Mombelli E; Maj C; Mora C; Etain B; Bellivier F; Marie-Claire C; Cattaneo A
BMC Psychiatry; 2022 Oct; 22(1):665. PubMed ID: 36303132
[TBL] [Abstract][Full Text] [Related]
6. Immunoglobulin genes expressed in lymphoblastoid cell lines discern and predict lithium response in bipolar disorder patients.
Mizrahi L; Choudhary A; Ofer P; Goldberg G; Milanesi E; Kelsoe JR; Gurwitz D; Alda M; Gage FH; Stern S
Mol Psychiatry; 2023 Oct; 28(10):4280-4293. PubMed ID: 37488168
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of depressive and bipolar disorder patients with mixed features.
Tondo L; Vázquez GH; Pinna M; Vaccotto PA; Baldessarini RJ
Acta Psychiatr Scand; 2018 Sep; 138(3):243-252. PubMed ID: 29862493
[TBL] [Abstract][Full Text] [Related]
8. Bipolar disorder and mechanisms of action of mood stabilizers.
Rapoport SI; Basselin M; Kim HW; Rao JS
Brain Res Rev; 2009 Oct; 61(2):185-209. PubMed ID: 19555719
[TBL] [Abstract][Full Text] [Related]
9. Translating neurotrophic and cellular plasticity: from pathophysiology to improved therapeutics for bipolar disorder.
Soeiro-de-Souza MG; Dias VV; Figueira ML; Forlenza OV; Gattaz WF; Zarate CA; Machado-Vieira R
Acta Psychiatr Scand; 2012 Nov; 126(5):332-41. PubMed ID: 22676371
[TBL] [Abstract][Full Text] [Related]
10. Disinhibition of the extracellular-signal-regulated kinase restores the amplification of circadian rhythms by lithium in cells from bipolar disorder patients.
McCarthy MJ; Wei H; Landgraf D; Le Roux MJ; Welsh DK
Eur Neuropsychopharmacol; 2016 Aug; 26(8):1310-9. PubMed ID: 27216486
[TBL] [Abstract][Full Text] [Related]
11. [Antipsychotics in bipolar disorders].
Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
[TBL] [Abstract][Full Text] [Related]
12. Translational evidence for lithium-induced brain plasticity and neuroprotection in the treatment of neuropsychiatric disorders.
Puglisi-Allegra S; Ruggieri S; Fornai F
Transl Psychiatry; 2021 Jul; 11(1):366. PubMed ID: 34226487
[TBL] [Abstract][Full Text] [Related]
13. Genetic influences on response to mood stabilizers in bipolar disorder: current status of knowledge.
Rybakowski JK
CNS Drugs; 2013 Mar; 27(3):165-73. PubMed ID: 23378337
[TBL] [Abstract][Full Text] [Related]
14. Mood stabilizers for patients with bipolar disorder: the state of the art.
Altamura AC; Lietti L; Dobrea C; Benatti B; Arici C; Dell'Osso B
Expert Rev Neurother; 2011 Jan; 11(1):85-99. PubMed ID: 21158558
[TBL] [Abstract][Full Text] [Related]
15. The effect of mood-stabilizing drugs on cytokine levels in bipolar disorder: A systematic review.
van den Ameele S; van Diermen L; Staels W; Coppens V; Dumont G; Sabbe B; Morrens M
J Affect Disord; 2016 Oct; 203():364-373. PubMed ID: 27344047
[TBL] [Abstract][Full Text] [Related]
16. Neural progenitor cells derived from lithium responsive and non-responsive bipolar disorder patients exhibit distinct sensitivity to cell death following methamphetamine.
Mishra HK; Mandyam AD; Trenet W; Wei H; Nievergelt CM; Maihofer AX; Shilling PD; Alda M; Gershon E; McInnis MG; ; Kelsoe JR; McCarthy MJ
Neuropharmacology; 2023 Mar; 226():109410. PubMed ID: 36608815
[TBL] [Abstract][Full Text] [Related]
17. Whole Genome Expression Analyses of miRNAs and mRNAs Suggest the Involvement of miR-320a and miR-155-3p and their Targeted Genes in Lithium Response in Bipolar Disorder.
Pisanu C; Merkouri Papadima E; Melis C; Congiu D; Loizedda A; Orrù N; Calza S; Orrù S; Carcassi C; Severino G; Ardau R; Chillotti C; Del Zompo M; Squassina A
Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31801218
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic potential of mood stabilizers lithium and valproic acid: beyond bipolar disorder.
Chiu CT; Wang Z; Hunsberger JG; Chuang DM
Pharmacol Rev; 2013 Jan; 65(1):105-42. PubMed ID: 23300133
[TBL] [Abstract][Full Text] [Related]
19. Influence of an interaction between lithium salts and a functional polymorphism in SLC1A2 on the history of illness in bipolar disorder.
Dallaspezia S; Poletti S; Lorenzi C; Pirovano A; Colombo C; Benedetti F
Mol Diagn Ther; 2012 Oct; 16(5):303-9. PubMed ID: 23023733
[TBL] [Abstract][Full Text] [Related]
20. Management of bipolar disorder.
Griswold KS; Pessar LF
Am Fam Physician; 2000 Sep; 62(6):1343-53, 1357-8. PubMed ID: 11011863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
